Similar articles

• Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: a randomized trial.

  International Breast Cancer Study Group (IBCSG). International Breast Cancer Study Group (IBCSG). J Natl Cancer Inst. 2002 Jul 17;94(14):1054-65. doi: 10.1093/jnci/94.14.1054. J Natl Cancer Inst. 2002. PMID: 12122096 Clinical Trial.
• Adjuvant treatment in node-negative, postmenopausal breast cancer.

  Hutchins LF, Arick CL. Hutchins LF, et al. Cancer Invest. 2001;19(7):706-22. doi: 10.1081/cnv-100106146. Cancer Invest. 2001. PMID: 11577812 Review. No abstract available.
• Adjuvant randomized trials of doxorubicin/cyclophosphamide versus doxorubicin/cyclophosphamide/tamoxifen and CMF chemotherapy versus tamoxifen in women with node-positive breast cancer.

  Kaufmann M, Jonat W, Abel U, Hilfrich J, Caffier H, Kreienberg R, Trams G, Brunnert K, Schermann J, Kleine W, et al. Kaufmann M, et al. J Clin Oncol. 1993 Mar;11(3):454-60. doi: 10.1200/JCO.1993.11.3.454. J Clin Oncol. 1993. PMID: 8445420 Clinical Trial.
• Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the National Cancer Institute of Canada Clinical Trials Group. Breast Cancer Site Group.

  Pritchard KI, Paterson AH, Fine S, Paul NA, Zee B, Shepherd LE, Abu-Zahra H, Ragaz J, Knowling M, Levine MN, Verma S, Perrault D, Walde PL, Bramwell VH, Poljicak M, Boyd N, Warr D, Norris BD, Bowman D, Armitage GR, Weizel H, Buckman RA. Pritchard KI, et al. J Clin Oncol. 1997 Jun;15(6):2302-11. doi: 10.1200/JCO.1997.15.6.2302. J Clin Oncol. 1997. PMID: 9196144 Clinical Trial.
• Adjuvant chemoendocrine therapy in postmenopausal breast cancer: cyclophosphamide, methotrexate, and fluorouracil dose and schedule may make a difference. International Breast Cancer Study Group.

  Goldhirsch A, Coates AS, Colleoni M, Castiglione-Gertsch M, Gelber RD. Goldhirsch A, et al. J Clin Oncol. 1998 Apr;16(4):1358-62. doi: 10.1200/JCO.1998.16.4.1358. J Clin Oncol. 1998. PMID: 9552037 Review.